- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.88 Å
- Oligo State
- homo-tetramer
- Ligands
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-FUC.2: 3 residues within 4Å:- Chain A: N.65, I.355
- Chain B: E.381
5 PLIP interactions:2 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:E.381, A:N.65
- Water bridges: B:E.381, A:R.349
- Hydrophobic interactions: A:I.355
NAG-FUC.6: 5 residues within 4Å:- Chain D: K.3, A.5, N.7, N.154
- Ligands: NAG.47
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:K.3, D:K.3
- 1 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x CA: CALCIUM ION(Non-covalent)
CA.7: 6 residues within 4Å:- Chain A: D.213, G.217, D.243, G.261, N.263, G.264
6 PLIP interactions:5 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.213, A:G.217, A:D.243, A:G.261, A:N.263, H2O.3
CA.8: 4 residues within 4Å:- Chain A: D.295, N.297, D.303, N.305
5 PLIP interactions:3 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.295, A:D.303, A:N.305, H2O.5, H2O.6
CA.25: 7 residues within 4Å:- Chain B: D.213, G.217, D.243, G.261, A.262, N.263, G.264
6 PLIP interactions:5 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.213, B:G.217, B:D.243, B:G.261, B:N.263, H2O.15
CA.26: 4 residues within 4Å:- Chain B: D.295, N.297, D.303, N.305
5 PLIP interactions:3 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.295, B:D.303, B:N.305, H2O.14, H2O.16
CA.36: 5 residues within 4Å:- Chain C: D.213, G.217, D.243, G.261, N.263
6 PLIP interactions:5 interactions with chain C, 1 Ligand-Water interactions- Metal complexes: C:D.213, C:G.217, C:D.243, C:G.261, C:N.263, H2O.29
CA.37: 4 residues within 4Å:- Chain C: D.295, N.297, D.303, N.305
5 PLIP interactions:3 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:D.295, C:D.303, C:N.305, H2O.32, H2O.35
CA.43: 5 residues within 4Å:- Chain D: D.213, G.217, D.243, G.261, N.263
6 PLIP interactions:5 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.213, D:G.217, D:D.243, D:G.261, D:N.263, H2O.42
CA.44: 4 residues within 4Å:- Chain D: D.295, N.297, D.303, N.305
5 PLIP interactions:3 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:D.295, D:D.303, D:N.305, H2O.43, H2O.43
- 4 x GJT: (3~{R},4~{R},5~{S})-4-acetamido-5-[4-(hydroxymethyl)-1,2,3-triazol-1-yl]-3-pentan-3-yloxy-cyclohexene-1-carboxylic acid(Non-covalent)
GJT.9: 17 residues within 4Å:- Chain A: R.37, E.38, L.53, I.68, K.69, D.70, R.71, R.75, W.98, R.144, S.166, E.196, E.197, R.212, N.214, R.287, Y.321
15 PLIP interactions:15 interactions with chain A- Hydrophobic interactions: A:E.196, A:N.214
- Hydrogen bonds: A:D.70, A:R.71, A:R.75, A:Y.321
- Water bridges: A:R.37, A:E.38, A:E.38, A:S.99, A:E.197, A:R.212
- Salt bridges: A:R.37, A:R.212, A:R.287
GJT.27: 15 residues within 4Å:- Chain B: R.37, E.38, K.69, D.70, R.71, R.75, W.98, R.144, S.166, E.196, E.197, R.212, N.214, R.287, Y.321
13 PLIP interactions:13 interactions with chain B- Hydrophobic interactions: B:E.196, B:N.214
- Hydrogen bonds: B:R.37, B:D.70, B:R.71, B:R.75, B:Y.321
- Water bridges: B:E.38, B:E.38, B:S.99, B:E.197
- Salt bridges: B:R.212, B:R.287
GJT.38: 16 residues within 4Å:- Chain C: R.37, E.38, L.53, K.69, D.70, R.71, R.75, W.98, R.144, S.166, E.196, E.197, R.212, N.214, R.287, Y.321
13 PLIP interactions:13 interactions with chain C- Hydrophobic interactions: C:E.196
- Hydrogen bonds: C:R.37, C:D.70, C:R.71, C:R.75, C:Y.321
- Water bridges: C:E.38, C:E.38, C:S.99, C:E.197, C:N.263
- Salt bridges: C:R.212, C:R.287
GJT.45: 17 residues within 4Å:- Chain D: R.37, E.38, L.53, I.68, K.69, D.70, R.71, R.75, W.98, R.144, S.166, E.196, E.197, R.212, N.214, R.287, Y.321
11 PLIP interactions:11 interactions with chain D- Hydrophobic interactions: D:W.98, D:E.196
- Hydrogen bonds: D:D.70, D:R.71, D:R.75, D:Y.321
- Water bridges: D:S.99, D:E.197
- Salt bridges: D:R.37, D:R.212, D:R.287
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.10: 3 residues within 4Å:- Chain A: K.3, N.154
- Ligands: NAG-NAG-FUC.1
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:K.3, A:N.154
- Water bridges: A:Q.227
NAG.28: 2 residues within 4Å:- Chain B: N.65, I.355
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:I.355
- Hydrogen bonds: B:N.65
NAG.29: 3 residues within 4Å:- Chain B: K.3, N.154
- Ligands: NAG-NAG-FUC.3
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:K.3
- Water bridges: B:N.154
NAG.39: 3 residues within 4Å:- Chain C: K.3, N.154
- Ligands: NAG-NAG-FUC.4
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.154
- Water bridges: C:Q.227
NAG.46: 2 residues within 4Å:- Chain D: N.65, R.349
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:N.65, D:R.349
NAG.47: 3 residues within 4Å:- Chain D: K.3, N.154
- Ligands: NAG-FUC.6
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:K.3, D:N.154
- 29 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.11: 4 residues within 4Å:- Chain A: C.11, P.12, R.338, N.368
Ligand excluded by PLIPEDO.12: 4 residues within 4Å:- Chain A: P.12, V.13, Y.272, W.277
Ligand excluded by PLIPEDO.13: 3 residues within 4Å:- Chain A: P.12, D.335, C.336
Ligand excluded by PLIPEDO.14: 6 residues within 4Å:- Chain A: R.246, N.248, D.249, R.280, K.282, I.284
Ligand excluded by PLIPEDO.15: 1 residues within 4Å:- Chain A: K.282
Ligand excluded by PLIPEDO.16: 4 residues within 4Å:- Chain A: S.286, R.287, P.350, K.351
Ligand excluded by PLIPEDO.17: 4 residues within 4Å:- Chain A: W.294, P.296, S.307, I.308
Ligand excluded by PLIPEDO.18: 2 residues within 4Å:- Chain A: N.353, T.354
Ligand excluded by PLIPEDO.19: 1 residues within 4Å:- Ligands: EDO.20
Ligand excluded by PLIPEDO.20: 1 residues within 4Å:- Ligands: EDO.19
Ligand excluded by PLIPEDO.21: 5 residues within 4Å:- Chain A: K.184, V.186, N.228, L.229, E.230
Ligand excluded by PLIPEDO.22: 2 residues within 4Å:- Chain A: P.191, Y.193
Ligand excluded by PLIPEDO.23: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPEDO.24: 4 residues within 4Å:- Chain A: D.311, G.314, W.374, S.375
Ligand excluded by PLIPEDO.30: 3 residues within 4Å:- Chain B: P.165, N.167, G.168
Ligand excluded by PLIPEDO.31: 5 residues within 4Å:- Chain A: N.128, I.130
- Chain B: Y.19, E.47, C.48
Ligand excluded by PLIPEDO.32: 1 residues within 4Å:- Chain B: N.305
Ligand excluded by PLIPEDO.33: 4 residues within 4Å:- Chain B: P.73, Y.74
- Chain C: E.317, P.377
Ligand excluded by PLIPEDO.34: 1 residues within 4Å:- Chain B: T.251
Ligand excluded by PLIPEDO.35: 3 residues within 4Å:- Chain B: Y.272, G.273, N.274
Ligand excluded by PLIPEDO.40: 4 residues within 4Å:- Chain C: C.11, P.12, R.338, N.368
Ligand excluded by PLIPEDO.41: 9 residues within 4Å:- Chain C: W.318, I.346, R.347, G.348, R.349, P.350, K.351, E.352, T.357
Ligand excluded by PLIPEDO.42: 4 residues within 4Å:- Chain C: W.294, P.296, S.307, I.308
Ligand excluded by PLIPEDO.48: 1 residues within 4Å:- Chain D: N.128
Ligand excluded by PLIPEDO.49: 7 residues within 4Å:- Chain C: Y.89, N.90, S.91, R.92
- Chain D: P.81, E.84, N.90
Ligand excluded by PLIPEDO.50: 7 residues within 4Å:- Chain C: N.128, G.129, I.130
- Chain D: Y.19, L.46, E.47, C.48
Ligand excluded by PLIPEDO.51: 5 residues within 4Å:- Chain D: D.118, N.119, N.140, N.141, I.142
Ligand excluded by PLIPEDO.52: 1 residues within 4Å:- Chain D: N.305
Ligand excluded by PLIPEDO.53: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIP- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zima, V. et al., Investigation of flexibility of neuraminidase 150-loop using tamiflu derivatives in influenza A viruses H1N1 and H5N1. Bioorg.Med.Chem. (2019)
- Release Date
- 2019-09-11
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.88 Å
- Oligo State
- homo-tetramer
- Ligands
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x CA: CALCIUM ION(Non-covalent)
- 4 x GJT: (3~{R},4~{R},5~{S})-4-acetamido-5-[4-(hydroxymethyl)-1,2,3-triazol-1-yl]-3-pentan-3-yloxy-cyclohexene-1-carboxylic acid(Non-covalent)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 29 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zima, V. et al., Investigation of flexibility of neuraminidase 150-loop using tamiflu derivatives in influenza A viruses H1N1 and H5N1. Bioorg.Med.Chem. (2019)
- Release Date
- 2019-09-11
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D